Patents for C12P 21 - Preparation of peptides or proteins (112,499)
04/1999
04/15/1999WO1999018122A1 Ama
04/15/1999WO1999017800A1 Secretory leukocyte protease inhibitor dry powder pharmaceutical compositions
04/15/1999WO1999017797A1 Use of growth differenciation factor-9 (gdf-9) as a contraceptive
04/15/1999WO1999017796A2 Modulation of lerk-2-mediated cell adhesion
04/15/1999WO1999017794A1 UDP-N-ACETYLMURAMOYL-L-AIANINE:D-GLUTAMATE LIGASE (murD) OF STAPHYLOCOCCUS AUREUS
04/15/1999WO1999008708A3 Method and food product for increasing muscle protein and reducing fat in animals
04/15/1999WO1999007738A3 Human orphan receptor ntr-1
04/15/1999WO1999005170A8 NOVEL ESTROGEN β RECEPTOR AND ISOFORMS
04/15/1999WO1999000010A3 TRANSGENIC ANIMALS EXPRESSING HUMAN Fc RECEPTORS
04/15/1999WO1998059058A3 Polynucleotides and their use for detecting resistance to streptogramin a or to streptogramin b and related compounds
04/15/1999WO1998048022A9 HUMAN COMPLEMENT C3-DEGRADING PROTEINASE FROM $i(STREPTOCOCCUS PNEUMONIAE)
04/15/1999WO1998047343A9 Antibodies or binding protein libraries displayed on phage, cells, or other replicatable genetic packages
04/15/1999DE19821060A1 Ko-stimulierendes Polypeptid von T-Zellen, monoklonale Antikörper sowie die Herstellung und deren Verwendung Co-stimulatory polypeptide of T-cells, monoclonal antibodies and the production and use thereof
04/15/1999DE19811047C1 Copper-containing ribonucleoproteins
04/15/1999DE19744655A1 Antibody specific for baculovirus, for detection of baculovirus
04/15/1999CA2308126A1 Modulation of lerk-2-mediated cell adhesion
04/15/1999CA2308123A1 Secretory leukocyte protease inhibitor dry powder pharmaceutical compositions
04/15/1999CA2306452A1 Use of growth differentiation factor-9 (gdf-9) as a contraceptive
04/15/1999CA2305814A1 Gankyrin
04/15/1999CA2305712A1 Natural humanized antibody
04/15/1999CA2305685A1 101 human secreted proteins
04/15/1999CA2305559A1 Methods of refolding proteins by use of zwitterionic low molecular weight agents
04/15/1999CA2273842A1 A human 2-19 protein homologue, z219a
04/14/1999EP0908517A2 Viral vaccines
04/14/1999EP0908516A1 ABC transporter
04/14/1999EP0908514A1 LicD1 polyperides from Streptococcus pneumoniae
04/14/1999EP0908466A1 Anti-human lect2 antibody, cells producing the same, and method and kit for assaying the same
04/14/1999EP0908105A1 Process for obtaining plant peptones with a high hydrolysis degree and applications thereof
04/14/1999EP0908093A1 Model transgenic animal for interleukin-1 relevant diseases
04/14/1999EP0907751A2 Dna, rna and a protein useful for detection of a mycobacterial infection
04/14/1999EP0907746A2 Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesis
04/14/1999EP0907738A1 Novel compounds
04/14/1999EP0907737A1 Il-6 mutein
04/14/1999EP0907736A2 Cc-type chemokines
04/14/1999EP0907735A1 Modulators of tissue regeneration
04/14/1999EP0907732A2 Polynucleotides encoding secreted proteins
04/14/1999EP0907731A1 Metabotropic gaba(b) receptors, receptor-specific ligands and their uses
04/14/1999EP0907730A1 Haemopoietin receptor and genetic sequences encoding same
04/14/1999EP0907729A1 HUMAN P2x4 RECEPTOR SPLICE-VARIANTS
04/14/1999EP0907377A1 Novel compounds
04/14/1999EP0907376A1 Novel compounds
04/14/1999EP0907375A1 Novel compounds
04/14/1999EP0907312A1 Compositions and methods for taxol biosynthesis
04/14/1999EP0777685B1 Antigenic peptides derived from the g protein of rsv for type- and subtype-specific diagnosis of respiratory syncytial virus (rsv) infection
04/14/1999EP0759934B1 Neurotensin antagonist peptides
04/14/1999EP0643559B1 Diphtheria toxin receptor-binding region
04/14/1999EP0550661B1 Uses of gro genes and proteins
04/14/1999EP0548200B1 Cloning and sequencing of allergens of dermatophagoides (house dust mite)
04/14/1999CN1214084A Cold-active protease CP70
04/14/1999CN1214080A Glycorprotein B of RFHV/KSHV subfamily of herpes viruses
04/14/1999CN1214052A Isolated dimeric fibroblast activation protein alpha, and uses thereof
04/14/1999CN1214050A Human tumor necrosis factor delta and epsilon
04/13/1999CA2169942C Multiple integrative vectors and yarrowia lipolytica transformants
04/13/1999CA2158750C Monoclonal antibodies to casein kinase i polypeptides
04/13/1999CA2079584C Methods for trans-destabilization of specific proteins in vivo
04/13/1999CA2000661C A process for the production of transgenic plants with increased nutritional value via the expression of modified 2s storage albumins
04/13/1999CA1340491C Interleukin-7
04/08/1999WO1999016884A1 Fusion proteins comprising hiv-1 tat and/or nef proteins
04/08/1999WO1999016877A1 Amino-terminally truncated rantes as chemokine antagonists
04/08/1999WO1999016876A1 Amino-terminally truncated mcp-2 as chemokine antagonists
04/08/1999WO1999016872A1 Isoforms of the human vitamin d receptor
04/08/1999WO1999016862A1 Lactobacillus helveticus bacterium having high capability of producing tripeptide, fermented milk product, and process for preparing the same
04/08/1999WO1999016784A1 Ras-binding protein (pre1)
04/08/1999WO1999016468A1 Antigen vectors in the form of multilamellar vesicles
04/08/1999WO1999016459A1 Apolipoprotein a-i agonists and their use to treat dyslipidemic disorders
04/08/1999WO1999006553A3 5' ESTs FOR SECRETED PROTEINS EXPRESSED IN VARIOUS TISSUES
04/08/1999WO1999006549A3 5' ESTs FOR SECRETED PROTEINS EXPRESSED IN TESTIS AND OTHER TISSUES
04/08/1999WO1999003987A3 Syncytial respiratory virus epitopes and antibodies comprising them, useful in diagnosis and therapy
04/08/1999WO1999003882A3 Human leukocyte calcium activated potassium channel polypeptide
04/08/1999WO1998057993A9 Secretory immunoglobulin produced by single cells and methods for making and using same
04/08/1999WO1998056811B1 Plant grab proteins
04/08/1999CA2305017A1 Amino-terminally truncated mcp-2 as chemokine antagonists
04/08/1999CA2305011A1 Isoforms of the human vitamin d receptor
04/08/1999CA2304827A1 Amino-terminally truncated rantes as chemokine antagonists
04/08/1999CA2304824A1 Antigen vectors in the form of multilamellar vesicles and compositions containing antigens encapsulated in these vesicles
04/08/1999CA2304805A1 Apolipoprotein a-i agonists and their use to treat dyslipidemic disorders
04/08/1999CA2304209A1 Ras-binding protein (pre1)
04/08/1999CA2245937A1 Novel histidine kinase
04/07/1999EP0906957A2 Lgt polypeptide
04/07/1999EP0906956A2 MurD from Streptococcus pneumoniae
04/07/1999EP0906955A2 FtsY
04/07/1999EP0906918A2 Process for production of insulin precursors having correctly linked cystein bridges
04/07/1999EP0906577A1 Screening compounds for the ability to alter the production of amyloid-beta peptide
04/07/1999EP0906433A1 Protein tyrosine phosphatases of hematopoietic cells
04/07/1999EP0906424A2 Mammalian mixed lymphocyte receptors, chemokine receptors mmlr-ccr]
04/07/1999EP0906423A1 Metastasis-associated antigen and antibodies thereto
04/07/1999EP0906422A1 Human cell death-associated protein
04/07/1999EP0906337A2 AN ANTIGENIC EPITOPE OF THE u A /u DETERMINANT OF HEPATITIS B SURFACE ANTIGEN AND USES THEREOF
04/07/1999EP0906336A1 Antibiotic producing microbe
04/07/1999EP0754227A4 Chimeric complement inhibitor proteins
04/07/1999EP0671471B1 Process for producing foreign protein
04/07/1999EP0642579B1 Improved methods for the preparation of endotoxin-binding proteins
04/07/1999EP0569531B1 Stabilized antibody fragments
04/07/1999CN1213407A Compositions and method for determining anti-viral drug susceptibility and resistance and anti-viral drug screening
04/07/1999CN1213406A Method for inhibiting adenylosuccinate synthetase activity methylthioadenosine phosphorylasse deficient cells
04/07/1999CN1213402A Recombinant expression of S-layer proteins
04/07/1999CN1213401A Exodus chemokine materials and method
04/07/1999CN1213378A Antitumor substance extracted from Grifola
04/07/1999CN1213312A Anticogulant agent useful in treatment of thrombosis
04/07/1999CA2249715A1 Abc transporter